image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Primary Recommendation

BTG - Varisolve may float next year

October 2003

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BGC
Last month, we made technology development company, British Technology Group, a trading buy at 250p and the shares have soared almost vertically from day one. The well-timed catalyst came in the shape of excellent trial data for its potential blockbuster,  Varisolve, a drug which could revolutionise the treatment of varicose veins by doing away with the need for surgery. Although BTG owns a plethora of other early stage products, it is Varisolve, (a product which is only two years from launch and which could eventually generateannual sales of £300m), that is currently mesmerising investors.  Broker, CSFB is so confident in its prospects that it has given a valueof 520p a share on Varisolve alone and estimates that fair value f ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

BTG - Blockbuster hopes for new varicose vein treatment (July 2008)
BTG (December 2003)
BTG - Likely beneficiary when IPO window re-opens (September 2003)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X